Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1983; Volume 23,Issue 3
  • You have access
    Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
    R A Frye and R W Holz
    Molecular Pharmacology May 1983, 23 (3) 547-550;
  • You have access
    Modification of the binding properties of muscarinic receptors by gallamine.
    J M Stockton, N J Birdsall, A S Burgen and E C Hulme
    Molecular Pharmacology May 1983, 23 (3) 551-557;
  • You have access
    The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
    C W Lin and J M Musacchio
    Molecular Pharmacology May 1983, 23 (3) 558-562;
  • You have access
    3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
    C M Lee, J A Javitch and S H Snyder
    Molecular Pharmacology May 1983, 23 (3) 563-569;
  • You have access
    Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
    P J Barnes, B E Skoogh, J A Nadel and J M Roberts
    Molecular Pharmacology May 1983, 23 (3) 570-575;
  • You have access
    Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    A Enjalbert and J Bockaert
    Molecular Pharmacology May 1983, 23 (3) 576-584;
  • You have access
    Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    D R Sibley and I Creese
    Molecular Pharmacology May 1983, 23 (3) 585-593;
  • You have access
    [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    D A Kendall, D P Taylor and S J Enna
    Molecular Pharmacology May 1983, 23 (3) 594-599;
  • You have access
    A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
    M E Reith, H Sershen, D L Allen and A Lajtha
    Molecular Pharmacology May 1983, 23 (3) 600-606;
  • You have access
    Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    A Dumbrille-Ross and S W Tang
    Molecular Pharmacology May 1983, 23 (3) 607-613;
  • You have access
    Ionization processes of some harmala alkaloids.
    K T Douglas, R K Sharma, J F Walmsley and R C Hider
    Molecular Pharmacology May 1983, 23 (3) 614-618;
  • You have access
    High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
    G L Craviso and J M Musacchio
    Molecular Pharmacology May 1983, 23 (3) 619-628;
  • You have access
    High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
    G L Craviso and J M Musacchio
    Molecular Pharmacology May 1983, 23 (3) 629-640;
  • You have access
    Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
    W L Combest and D H Russell
    Molecular Pharmacology May 1983, 23 (3) 641-647;
  • You have access
    Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
    G S Johnson and C J Jaworski
    Molecular Pharmacology May 1983, 23 (3) 648-652;
  • You have access
    Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
    Molecular Pharmacology May 1983, 23 (3) 653-664;
  • You have access
    Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    P J Silver and J T Stull
    Molecular Pharmacology May 1983, 23 (3) 665-670;
  • You have access
    Ionic and metabolic requirements for stimulation of secretion by ouabain in bovine adrenal medullary cells.
    G Pocock
    Molecular Pharmacology May 1983, 23 (3) 671-680;
  • You have access
    Ion movements in isolated bovine adrenal medullary cells treated with ouabain.
    G Pocock
    Molecular Pharmacology May 1983, 23 (3) 681-697;
  • You have access
    Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
    G Jung, G Hennings, M Pfeifer and W G Bessler
    Molecular Pharmacology May 1983, 23 (3) 698-702;
  • You have access
    Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
    M C Edwards, A M Nouri, D Gordon and F J Evans
    Molecular Pharmacology May 1983, 23 (3) 703-708;
  • You have access
    Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    P H Fischer, M A Weddle and R D Mossie
    Molecular Pharmacology May 1983, 23 (3) 709-716;
  • You have access
    Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
    J M Chemnitius and R Zech
    Molecular Pharmacology May 1983, 23 (3) 717-723;
  • You have access
    Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
    K A Black and T R Tephly
    Molecular Pharmacology May 1983, 23 (3) 724-730;
  • You have access
    Identification of 2-imidazolines as anti-sickling agents.
    H Chang, S M Ewert and R L Nagel
    Molecular Pharmacology May 1983, 23 (3) 731-734;
  • You have access
    Modulation of microsomal benzo[a]pyrene metabolism by DNA.
    G M Keller and C R Jefcoate
    Molecular Pharmacology May 1983, 23 (3) 735-742;
  • You have access
    22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
    J D Lambeth
    Molecular Pharmacology May 1983, 23 (3) 743-747;
  • You have access
    Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    E H Jeffery and G J Mannering
    Molecular Pharmacology May 1983, 23 (3) 748-757;
  • You have access
    Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
    G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
    Molecular Pharmacology May 1983, 23 (3) 758-760;
  • You have access
    Cysteine conjugate beta-lyase.
    J Stevens and W B Jakoby
    Molecular Pharmacology May 1983, 23 (3) 761-765;
  • You have access
    An electron spin resonance study of the activation of benzidine by peroxidases.
    P D Josephy, T E Eling and R P Mason
    Molecular Pharmacology May 1983, 23 (3) 766-770;
  • You have access
    Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
    G Benga, M Ionescu, O Popescu and V I Pop
    Molecular Pharmacology May 1983, 23 (3) 771-778;
  • You have access
    Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
    J L Vannice, J R Grove and G M Ringold
    Molecular Pharmacology May 1983, 23 (3) 779-785;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 23, Issue 3
1 May 1983
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics